Committee on International Relations
U.S. House of Representatives
Henry J. Hyde, Chairman

CONTACT: Sam Stratman, (202) 226-7875, March 16, 2005

horizontal rule


Combating Malaria and Tuberculosis
Christopher Smith Schedules Tuesday Hearing on Implementing Proven Treatment and Eradication Methods

BACKGROUND:  The global pandemic of HIV/AIDS is frequently the focus of high-profile news coverage, but much of the developing world is being ravaged by two other, relatively unknown, killer diseases:  malaria and tuberculosis (TB).  One-third of the world is infected with the TB bacterium, and it is the leading cause of death for people with HIV/AIDS.  Africa is currently experiencing a TB explosion due in large part to the AIDS pandemic.  Similarly, Malaria is the primary killer of children and pregnant women in Africa, and one of the top killers in Asia and South America.  Every day about 3,000 children die from the disease worldwide.  Infection rates for malaria dwarf those of HIV/AIDS, and the vast majority of malaria patients are pregnant women and children living in poverty.  However, both diseases are preventable and curable.  A six-month course of anti-TB drugs costs only $12 and can produce cure rates of up to 95 percent even in the poorest countries. Malaria, likewise, is inexpensive and easy to treat, and can be controlled with proven successful methods combining anti-malarial drugs, bed nets, and use of small, environmentally safe amounts of insecticide in homes and buildings.  In FY 2005, the United States will provide $2.9 billion in bilateral and multilateral assistance to fight HIV/AIDS, malaria and tuberculosis.  Among the witnesses scheduled to testify Tuesday is Youssou N’Dour, Senegalese Jazz Musician, Goodwill Ambassador, and Roll Back Malaria Partnership.


WHAT:              Subcommittee Oversight Hearing: Malaria and TB: Implementing Proven Treatment
                           and Eradication Methods
Subcommittee on Africa, Global Human Rights and International Operations,
U.S. Rep. Christopher H. Smith (R-NJ), Chairman

WHEN:             2:00 p.m., Tuesday, April 26, 2005

WHERE:           Room 2172 Rayburn House Office Building

WITNESSES:   Mark Dybul, M.D., Assistant U.S. Global AIDS Coordinator and Chief Medical Officer, Office of the
   U.S. Global AIDS Coordinator, U.S. Department of State;
   Michael Miller,
Deputy Assistant Administrator, Bureau for Global Health, U.S. Agency for
   International Development;
   William Moeller,
President and CEO, American Biotech Labs;
   Youssou N’Dour,
Senegalese Jazz Musician, Goodwill Ambassador, Roll Back Malaria Partnership; and
   Paul Nunn, M.D., Coordinator, TB, HIV, and Drug Resistance Unit, World Health Organization.

Back to Press Page      Home